Evaluation of the efficacy of Simparica Trio® in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs

Stasia Borowski,Alta Viljoen,Lina D’Hanis,Sean Mahabir,Thomas Geurden
DOI: https://doi.org/10.1186/s13071-023-06115-2
2024-02-04
Parasites & Vectors
Abstract:Babesia canis is a clinically relevant vector-borne pathogen in dogs, and its presence is expanding. The efficacy of Simparica Trio ® (Zoetis) in the prevention of B. canis transmission was evaluated at the minimum recommended label dose of 1.2 mg/kg sarolaner, 24 μg/kg moxidectin and 5 mg/kg pyrantel per kg bodyweight.
tropical medicine,parasitology
What problem does this paper attempt to address?